Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study

dc.contributor.author	Ozgun, MA; Dogan, I; Eryilmaz, MK; Erdogan, AP; Ayhan, M; Hafizoglu, E; Tolunay, PK; Cavdar, E; Cevik, GT; Demir, H; Dulgar, O; Yilmaz, B; Cakir, E; Gokyer, A; Unal, OU; Perkin, P; Sakalar, T; Gulmez, A; Tasci, ES; Lacin, S
dc.date.accessioned	2023-03-02T06:39:21Z
dc.date.available	2023-03-02T06:39:21Z
dc.date.issued	2021
dc.identifier.uri	http://hdl.handle.net/20.500.12481/14357
dc.title	Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study
dc.title.alternative	ANNALS OF ONCOLOGY
dc.identifier.DOI-ID	10.1016/j.annonc.2021.08.1461
dc.identifier.volume	32
dc.identifier.startpage	S892
dc.identifier.endpage	S892
dc.identifier.issn/e-issn	0923-7534
dc.identifier.issn/e-issn	1569-8041

Files in this item

Files	Size	Format	View
There are no files associated with this item.